Winston Pharmaceuticals 

$0.000100
2
+$0.00+0% Thursday 20:00

Statistics

Day High
0.0001
Day Low
0.0001
52W High
0.0003
52W Low
0.0001
Volume
16,186
Avg. Volume
0
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

31MarExpected
Q2 2008
Q3 2008
Q4 2008
Q1 2009
Q2 2009
Q3 2009
Q4 2009
-0.02
-0.02
-0.01
-0.01
Expected EPS
N/A
Actual EPS
-0.006

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Pfizer
PFE
Mkt Cap159.36B
Pfizer Inc. is a direct competitor in the pharmaceutical industry, focusing on similar therapeutic areas and drug development.
Merck
MRK
Mkt Cap366B
Merck & Co., Inc. competes in the same sectors of pharmaceuticals, particularly in the development of prescription medicines and vaccines.
Johnson & Johnson
JNJ
Mkt Cap645.95B
Johnson & Johnson operates in the same industry, producing a broad range of healthcare products including pharmaceuticals that directly compete with Winston Pharmaceuticals.
Abbvie
ABBV
Mkt Cap451.46B
AbbVie Inc. is a competitor due to its focus on research-based pharmaceuticals, directly competing in key therapeutic areas.
Lilly(Eli) &
LLY
Mkt Cap1.05T
Eli Lilly and Company is a major player in the pharmaceutical industry, with a strong emphasis on medication for diabetes and cancer, competing in similar markets as Winston Pharmaceuticals.
Bristol-Myers Squibb
BMY
Mkt Cap136B
Bristol-Myers Squibb Company operates in the global biopharmaceutical industry, directly competing with Winston Pharmaceuticals in multiple therapeutic areas.
GSK
GSK
Mkt Cap101.78B
GlaxoSmithKline plc competes with Winston Pharmaceuticals in the development and marketing of prescription medications and vaccines.
Novartis
NVS
Mkt Cap292.35B
Novartis AG is known for its innovative medicines and directly competes in the same therapeutic areas as Winston Pharmaceuticals.
Sanofi
SNY
Mkt Cap107.39B
Sanofi focuses on pharmaceuticals and biotechnology, directly competing with Winston Pharmaceuticals in areas like diabetes solutions and human vaccines.
Astrazeneca
AZN
Mkt Cap252.33B
AstraZeneca PLC competes in the global biopharmaceutical market, focusing on similar therapeutic areas as Winston Pharmaceuticals.

About

Winston Pharmaceuticals, Inc. (WPHM) is a biopharmaceutical firm dedicated to the discovery, development, and market introduction of innovative treatments for pain. The company's pipeline and offerings address a broad spectrum of painful conditions, encompassing episodic cluster headaches, chronic migraines, various neuropathic pain syndromes, and discomfort associated with both osteoarthritis and rheumatoid arthritis. They also tackle pain and inflammation linked to inflammatory bowel disease, alongside other specialized therapeutic areas. The organization, initially established as Winston Laboratories, Inc., adopted its present name, Winston Pharmaceuticals, Inc., in November 2008. Founded in 1998, Winston Pharmaceuticals maintains its principal operations in Vernon Hills, Illinois.
Show more...
CEO
Joel E. Bernstein
Employees
9
Country
United States
ISIN
US9756571074

Listings

0 Comments

Share your thoughts

FAQ

What is Winston Pharmaceuticals stock price today?
The current price of WPHM is $0.00 USD — it has increased by +0% in the past 24 hours. Watch Winston Pharmaceuticals stock price performance more closely on the chart.
What is Winston Pharmaceuticals stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange Winston Pharmaceuticals stocks are traded under the ticker WPHM.
Is Winston Pharmaceuticals stock price growing?
WPHM stock has risen by +0% compared to the previous week, the month change is a +0% rise, over the last year Winston Pharmaceuticals has showed a -66.67% decrease.
What were Winston Pharmaceuticals earnings last quarter?
WPHM earnings for the last quarter are -0.01 USD per share, whereas the estimation was N/A USD resulting in a N/A surprise. The estimated earnings for the next quarter are N/A USD per share.
How many employees does Winston Pharmaceuticals have?
As of September 04, 2026, the company has 9 employees.
In which sector is Winston Pharmaceuticals located?
Winston Pharmaceuticals operates in the Health & Wellness sector.
When did Winston Pharmaceuticals complete a stock split?
The last stock split for Winston Pharmaceuticals was on January 16, 2009 with a ratio of 1:8.
Where is Winston Pharmaceuticals headquartered?
Winston Pharmaceuticals is headquartered in Vernon Hills, United States.